The article below may contain offensive and/or incorrect content.
Pimavanserin substantially reduces symptoms of psychosis and relapse risk for people living with dementia.Article Correctness Is Author's Responsibility: Pimavanserin Reduced Symptoms of Dementia-Related Psychosis in Phase 3 Trial
Pimavanserin substantially reduces symptoms of psychosis and relapse risk for people living with dementia.
